Data is not available at this time.
Raisio plc operates in the packaged foods sector, specializing in grain-based foods, plant stanol esters, and fish feeds under well-known brands like Benecol and Elovena. The company serves both industrial clients and retail consumers across Finland, the UK, Poland, and other European markets, leveraging its expertise in healthy food and ingredient solutions. Its diversified product portfolio, including oat-based ingredients and plant stanol esters, positions it as a niche player in functional and heart-healthy foods. Raisio’s market presence is bolstered by strong brand recognition in Northern Europe, though it faces competition from larger multinational food corporations. The company’s focus on health-conscious products aligns with growing consumer demand for functional and sustainable food options, providing a competitive edge in specialized segments. Additionally, its involvement in fish feed production underlines a strategic diversification beyond human nutrition.
Raisio reported revenue of €226.8 million for the latest fiscal period, with net income of €16.9 million, reflecting moderate profitability in a competitive industry. The company’s operating cash flow of €39.3 million indicates solid cash generation, while capital expenditures of €6.7 million suggest disciplined reinvestment. Its ability to maintain positive earnings despite sector pressures highlights operational efficiency.
With diluted EPS of €0.11, Raisio demonstrates modest but stable earnings power. The absence of total debt and €26.6 million in cash reserves underscore strong capital efficiency, allowing flexibility for growth or shareholder returns. The company’s focus on high-margin functional foods likely supports its earnings resilience.
Raisio’s balance sheet is robust, with no debt and €26.6 million in cash and equivalents, providing a conservative financial structure. This liquidity position enhances its ability to navigate market volatility or invest in strategic initiatives without leveraging. The lack of debt also reduces financial risk, supporting long-term stability.
Raisio’s growth is tempered by its niche market focus, though demand for health-focused products offers opportunities. The company pays a dividend of €0.14 per share, reflecting a commitment to returning capital to shareholders. Future growth may depend on expanding its functional food offerings or entering new geographic markets.
With a market cap of approximately €366 million, Raisio trades at a valuation reflective of its steady but slow-growth profile. Its beta of 0.499 suggests lower volatility compared to the broader market, aligning with its defensive sector positioning. Investors likely value its stability and dividend yield over aggressive expansion.
Raisio’s strategic advantages lie in its strong brand portfolio and expertise in heart-healthy ingredients. The outlook remains stable, supported by trends toward functional foods, though competition and regional market saturation could limit upside. Continued innovation and potential geographic expansion are key to sustaining growth.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |